DF/BWCC 2020 Collaborative Symposium

October 15, 2020


The course is designed to give medical oncologists, radiation oncologists, midlevel providers (e.g. nurse practitioners and physician assistants) and nurses, updated information regarding the management of a broad spectrum of cancer types. The Dana-Farber/Brigham and Women’s Cancer Center (DFBWCC) has a robust faculty of sub-specialized medical and radiation oncologists who possess the most up-to-date expertise, best practices, research, and findings on virtually all cancer types. For this activity, subspecialists from the DFBWCC will discuss specifically: 1) Hypersensitivity Identification, Treatment and Workflow 2) New Approaches in Palliative Radiotherapy 3) Team Building and Collaboration

Target Audience

This activity is intended for the Dana-Farber Cancer Care Collaborative (The Collaborative). This includes clinical staff (physicians, nurses, mid-level practitioners) at the cancer centers throughout New England. These sites include: Berkshire Medical Center in Pittsfield, MA; Cape Cod Hospital in Hyannis, MA; UMass Memorial Hospital in Worcester, MA; New England Cancer Specialists in Scarborough, ME; Northern Light Health EMMC in Bangor, ME; Stamford Hospital in Stamford CT.


Learning Objectives

Upon completion of this activity, attendees will be able to:

  1. Recognize and subsequently mitigate potential risk associated with medication related infusion reactions by adopting an updated hypersensitivity reaction algorithm and clinical workflow as outlined and demonstrated by DFCI/BWH.
  2. Apply knowledge of advances in palliative radiotherapy to the care of patients with cancer.
  3. Evaluate their current teams and adopt recommendations outlined in the presentation in order to improve their teams’ efficacy and promote a more productive and collaborative workgroup.

Additional Information

Provided by: 

The Dana-Farber Cancer Care Collaborative & Mass General Brigham

Course summary
Available credit: 
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 Nursing Contact Hours
  • 3.00 Participation
Course opens: 
Course expires: 
Event starts: 
10/15/2020 - 1:00pm EDT
Event ends: 
10/15/2020 - 4:20pm EDT
1:00pmTeam Building and Collaboration
Craig Bunnell, MD
Anne Gross, PhD, RN, NEA-BC
2:10Hypersensitivity Identification, Treatment and Workflow
Mariana Castells, MD, PhD
Donna-Marie Lynch, NP
Bridget Scullion, PharmD
3:10 Break
3:20New Approaches in Palliative Radiotherapy
Tracy A. Balboni, MD, MPH


Dana-Farber Cancer Institute
United States

Course Director

Rachel Freedman, MD, MPH
Medical Director, DFCI Cancer Care Collaborative,
Senior Physician, Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School


Tracy A. Balboni, MD, MPH
Clinical Director, Supportive and Palliative Radiation Oncology Service,
Dana-Farber/Brigham and Women's Cancer Center

Craig Bunnell, MD
Chief Medical Officer, Dana-Farber Cancer Institute

Mariana Castells, MD, PhD
Director, Drug Hypersensitivity and Desensitization Center,
Director Mastocytosis Center,
Brigham and Women's Hospital

Anne Gross, PhD, RN, NEA-BC
Senior Vice President, Patient Care Services and Chief Nursing Officer,
Dana-Farber Cancer Institute

Donna-Marie Lynch, NP
Department of Medicine, Rheumatology, Immunology,
Brigham and Women's Hospital,

Bridget Scullion PharmD, BCOP
Clinical Pharmacy Manager,
Department of Pharmacy,
Dana-Farber Cancer Institute




Mass General Brigham is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Mass General Brigham designates this live activity for a maximum of 3 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Dana-Farber Cancer Institute is approved as a provider of nursing continuing professional development by the American Nurses Association Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Up to 3.00 Contact Hours of Nursing Continuing Professional Development (NCPD) will be awarded for attending the sessions and completing evaluations. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 Nursing Contact Hours
  • 3.00 Participation


Please login or register to take this course.